| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.961 | 0.002 | 0.964 | Psychostimulant | 0.964 0.002 DBMET00375 0.964 0.002 DBMET00962 0.948 0.002 DBMET00843 | DBMET00962 | |
| 0.913 | 0.003 | 0.913 | Spasmolytic | 0.884 0.003 DBMET00375 0.884 0.003 DBMET00962 0.709 0.005 DBMET00843 | ||
| 0.913 | 0.004 | 0.913 | Analgesic | 0.867 0.005 DBMET00375 0.867 0.005 DBMET00962 0.888 0.005 DBMET00843 | ||
| 0.768 | 0.005 | 0.768 | Aldehyde oxidase inhibitor | 0.45 0.04 DBMET00375 0.45 0.04 DBMET00962 0.556 0.025 DBMET00843 | ||
| 0.758 | 0.003 | 0.758 | Analgesic, opioid | 0.639 0.003 DBMET00375 0.639 0.003 DBMET00962 0.682 0.003 DBMET00843 | ||
| 0.62 | 0.003 | 0.622 | Opioid mu receptor agonist | 0.467 0.003 DBMET00375 0.467 0.003 DBMET00962 0.622 0.003 DBMET00843 | DBMET00843 | |
| 0.62 | 0.004 | 0.62 | Opioid antagonist | 0.493 0.004 DBMET00375 0.493 0.004 DBMET00962 0.605 0.004 DBMET00843 | ||
| 0.598 | 0.003 | 0.598 | Opioid mu receptor antagonist | 0.498 0.004 DBMET00375 0.498 0.004 DBMET00962 0.594 0.003 DBMET00843 | ||
| 0.589 | 0.008 | 0.589 | Potassium channel (Voltage-sensitive) blocker | 0.403 0.026 DBMET00375 0.403 0.026 DBMET00962 0.399 0.027 DBMET00843 | ||
| 0.563 | 0.003 | 0.563 | Opioid agonist | 0.366 0.004 DBMET00375 0.366 0.004 DBMET00962 0.555 0.003 DBMET00843 | ||
| 0.57 | 0.018 | 0.754 | 5 Hydroxytryptamine release stimulant | 0.754 0.005 DBMET00375 0.754 0.005 DBMET00962 0.745 0.005 DBMET00843 | DBMET00962 | |
| 0.524 | 0.007 | 0.524 | P-glycoprotein inhibitor | 0.328 0.024 DBMET00375 0.328 0.024 DBMET00962 0.357 0.02 DBMET00843 | ||
| 0.49 | 0.005 | 0.49 | Cholinergic antagonist | 0.349 0.01 DBMET00375 0.349 0.01 DBMET00962 0.223 0.026 DBMET00843 | ||
| 0.469 | 0.005 | 0.469 | Acetylcholine antagonist | 0.313 0.013 DBMET00375 0.313 0.013 DBMET00962 0.211 0.028 DBMET00843 | ||
| 0.53 | 0.076 | 0.542 | Antiinflammatory | 0.518 0.08 DBMET00375 0.518 0.08 DBMET00962 0.542 0.071 DBMET00843 | DBMET00843 | |
| 0.436 | 0.022 | 0.436 | HERG channel blocker | 0.217 0.081 DBMET00375 0.217 0.081 DBMET00962 0.206 0.087 DBMET00843 | ||
| 0.41 | 0.021 | 0.41 | Potassium channel blocker | 0.273 0.056 DBMET00375 0.273 0.056 DBMET00962 0.213 0.084 DBMET00843 | ||
| 0.387 | 0.007 | 0.387 | Anesthetic local | 0.253 0.019 DBMET00375 0.253 0.019 DBMET00962 0.257 0.019 DBMET00843 | ||
| 0.384 | 0.03 | 0.428 | Hypoglycemic | 0.273 0.064 DBMET00375 0.273 0.064 DBMET00962 0.428 0.023 DBMET00843 | DBMET00843 | |
| 0.34 | 0.005 | 0.34 | Acetylcholine nicotinic antagonist | 0.258 0.009 DBMET00375 0.258 0.009 DBMET00962 0.147 0.021 DBMET00843 | ||
| 0.38 | 0.086 | 0.38 | Histamine release inhibitor | 0.373 0.089 DBMET00375 0.373 0.089 DBMET00962 0.302 0.122 DBMET00843 | ||
| 0.348 | 0.056 | 0.348 | Vasodilator, coronary | 0.314 0.077 DBMET00375 0.314 0.077 DBMET00962 0.327 0.068 DBMET00843 | ||
| 0.307 | 0.077 | 0.348 | Immunostimulant | 0.232 0.104 DBMET00375 0.232 0.104 DBMET00962 0.348 0.065 DBMET00843 | DBMET00843 | |
| 0.278 | 0.052 | 0.332 | DNA synthesis inhibitor | 0.258 0.061 DBMET00375 0.258 0.061 DBMET00962 0.332 0.034 DBMET00843 | DBMET00843 | |
| 0.28 | 0.057 | 0.433 | 5 Hydroxytryptamine uptake stimulant | 0.285 0.054 DBMET00375 0.285 0.054 DBMET00962 0.433 0.009 DBMET00843 | DBMET00843 | |
| 0.338 | 0.126 | 0.454 | 5 Hydroxytryptamine release inhibitor | 0.343 0.122 DBMET00375 0.343 0.122 DBMET00962 0.454 0.05 DBMET00843 | DBMET00843 | |
| 0.349 | 0.139 | 0.63 | Apoptosis agonist | 0.63 0.043 DBMET00375 0.63 0.043 DBMET00962 0.302 0.171 DBMET00843 | DBMET00962 | |
| 0.225 | 0.019 | 0.225 | Acetylcholine muscarinic antagonist | 0.132 0.056 DBMET00375 0.132 0.056 DBMET00962 0.111 0.077 DBMET00843 | ||
| 0.26 | 0.068 | 0.28 | Gastrin inhibitor | 0.28 0.048 DBMET00375 0.28 0.048 DBMET00962 0.261 0.067 DBMET00843 | DBMET00962 | |
| 0.254 | 0.067 | 0.273 | Vasodilator | 0.206 0.1 DBMET00375 0.206 0.1 DBMET00962 0.273 0.058 DBMET00843 | DBMET00843 | |
| 0.285 | 0.101 | 0.285 | Cholesterol antagonist | 0.237 0.135 DBMET00375 0.237 0.135 DBMET00962 0.276 0.107 DBMET00843 | ||
| 0.28 | 0.1 | 0.28 | Apoptosis antagonist | 0.229 0.148 DBMET00843 | ||
| 0.275 | 0.096 | 0.275 | Immunomodulator | 0.184 0.182 DBMET00843 | ||
| 0.247 | 0.068 | 0.247 | Hypolipemic | 0.148 0.139 DBMET00375 0.148 0.139 DBMET00962 0.149 0.137 DBMET00843 | ||
| 0.245 | 0.082 | 0.326 | Interleukin agonist | 0.267 0.067 DBMET00375 0.267 0.067 DBMET00962 0.326 0.037 DBMET00843 | DBMET00843 | |
| 0.167 | 0.011 | 0.167 | Neuronal nicotinic receptor antagonist | 0.129 0.015 DBMET00375 0.129 0.015 DBMET00962 0.078 0.038 DBMET00843 | ||
| 0.18 | 0.025 | 0.18 | Microtubule formation inhibitor | 0.175 0.027 DBMET00375 0.175 0.027 DBMET00962 0.164 0.031 DBMET00843 | ||
| 0.197 | 0.044 | 0.197 | Acetylcholine M1 receptor antagonist | 0.122 0.106 DBMET00375 0.122 0.106 DBMET00962 0.124 0.103 DBMET00843 | ||
| 0.209 | 0.07 | 0.219 | Anesthetic general | 0.176 0.089 DBMET00375 0.176 0.089 DBMET00962 0.219 0.065 DBMET00843 | DBMET00843 | |
| 0.253 | 0.125 | 0.343 | Vasodilator, peripheral | 0.343 0.077 DBMET00375 0.343 0.077 DBMET00962 0.223 0.151 DBMET00843 | DBMET00962 | |
| 0.171 | 0.044 | 0.205 | Alpha-N-acetylglucosaminidase inhibitor | 0.19 0.037 DBMET00375 0.19 0.037 DBMET00962 0.205 0.033 DBMET00843 | DBMET00843 | |
| 0.179 | 0.055 | 0.179 | Arachidonic acid antagonist | 0.151 0.087 DBMET00375 0.151 0.087 DBMET00962 0.168 0.067 DBMET00843 | ||
| 0.257 | 0.142 | 0.455 | Immunosuppressant | 0.305 0.112 DBMET00375 0.305 0.112 DBMET00962 0.455 0.045 DBMET00843 | DBMET00843 | |
| 0.179 | 0.065 | 0.179 | MAP kinase kinase 5 inhibitor | 0.166 0.096 DBMET00375 0.166 0.096 DBMET00962 0.172 0.082 DBMET00843 | ||
| 0.119 | 0.012 | 0.119 | Elastase 1 inhibitor | 0.088 0.029 DBMET00375 0.088 0.029 DBMET00962 0.095 0.023 DBMET00843 | ||
| 0.24 | 0.134 | 0.347 | Antithrombotic | 0.347 0.066 DBMET00375 0.347 0.066 DBMET00962 0.31 0.082 DBMET00843 | DBMET00962 | |
| 0.148 | 0.047 | 0.184 | Cathepsin H inhibitor | 0.13 0.064 DBMET00375 0.13 0.064 DBMET00962 0.184 0.028 DBMET00843 | DBMET00843 | |
| 0.148 | 0.047 | 0.15 | Ca2+-transporting ATPase inhibitor | 0.139 0.077 DBMET00375 0.139 0.077 DBMET00962 0.15 0.043 DBMET00843 | DBMET00843 | |
| 0.107 | 0.013 | 0.147 | Neuraminidase inhibitor | 0.131 0.008 DBMET00375 0.131 0.008 DBMET00962 0.147 0.006 DBMET00843 | DBMET00843 | |
| 0.168 | 0.083 | 0.168 | Lipocortins synthesis antagonist | 0.155 0.098 DBMET00375 0.155 0.098 DBMET00962 0.15 0.105 DBMET00843 | ||
| 0.146 | 0.062 | 0.146 | Calcium channel blocker | 0.111 0.099 DBMET00375 0.111 0.099 DBMET00962 | ||
| 0.119 | 0.035 | 0.119 | Calcium antagonist | 0.077 0.067 DBMET00375 0.077 0.067 DBMET00962 | ||
| 0.123 | 0.044 | 0.123 | Acetylcholine release stimulant | 0.113 0.061 DBMET00375 0.113 0.061 DBMET00962 0.113 0.061 DBMET00843 | ||
| 0.204 | 0.128 | 0.297 | Tyrosine 3 hydroxylase inhibitor | 0.211 0.117 DBMET00375 0.211 0.117 DBMET00962 0.297 0.035 DBMET00843 | DBMET00843 | |
| 0.115 | 0.041 | 0.115 | Uric acid excretion stimulant | |||
| 0.143 | 0.075 | 0.165 | Adenylate cyclase stimulant | 0.155 0.055 DBMET00375 0.155 0.055 DBMET00962 0.165 0.041 DBMET00843 | DBMET00843 | |
| 0.084 | 0.02 | 0.084 | Cathepsin E inhibitor | 0.063 0.037 DBMET00375 0.063 0.037 DBMET00962 0.067 0.033 DBMET00843 | ||
| 0.095 | 0.032 | 0.095 | Estrogen-related receptor beta agonist | 0.084 0.054 DBMET00375 0.084 0.054 DBMET00962 | ||
| 0.149 | 0.088 | 0.291 | Growth hormone agonist | 0.165 0.076 DBMET00375 0.165 0.076 DBMET00962 0.291 0.034 DBMET00843 | DBMET00843 | |
| 0.277 | 0.22 | 0.369 | Caspase 9 stimulant | 0.369 0.131 DBMET00375 0.369 0.131 DBMET00962 0.26 0.241 DBMET00843 | DBMET00962 | |
| 0.122 | 0.066 | 0.141 | Alkylator | 0.119 0.069 DBMET00375 0.119 0.069 DBMET00962 0.141 0.052 DBMET00843 | DBMET00843 | |
| 0.081 | 0.025 | 0.127 | Neuraminidase (influenza) inhibitor | 0.103 0.016 DBMET00375 0.103 0.016 DBMET00962 0.127 0.01 DBMET00843 | DBMET00843 | |
| 0.076 | 0.026 | 0.076 | Androgen agonist | |||
| 0.164 | 0.114 | 0.194 | Insulin sensitizer | 0.147 0.138 DBMET00375 0.147 0.138 DBMET00962 0.194 0.08 DBMET00843 | DBMET00843 | |
| 0.165 | 0.117 | 0.165 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.158 0.13 DBMET00843 | ||
| 0.052 | 0.006 | 0.052 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.112 | 0.067 | 0.115 | Photosensitizer | 0.115 0.063 DBMET00843 | DBMET00843 | |
| 0.057 | 0.015 | 0.069 | Neuraminidase (Influenza A) inhibitor | 0.068 0.008 DBMET00375 0.068 0.008 DBMET00962 0.069 0.008 DBMET00843 | DBMET00843 | |
| 0.088 | 0.047 | 0.088 | Opioid kappa receptor antagonist | |||
| 0.119 | 0.079 | 0.168 | Cyclooxygenase 3 inhibitor | 0.117 0.081 DBMET00375 0.117 0.081 DBMET00962 0.168 0.034 DBMET00843 | DBMET00843 | |
| 0.063 | 0.025 | 0.063 | Acetyl-CoA transferase 2 inhibitor | 0.054 0.047 DBMET00375 0.054 0.047 DBMET00962 0.054 0.047 DBMET00843 | ||
| 0.076 | 0.038 | 0.076 | Opioid delta receptor antagonist | 0.061 0.046 DBMET00843 | ||
| 0.051 | 0.014 | 0.051 | Squalene synthetase inhibitor | 0.043 0.017 DBMET00375 0.043 0.017 DBMET00962 0.048 0.015 DBMET00843 | ||
| 0.095 | 0.061 | 0.095 | Prolactin inhibitor | 0.094 0.062 DBMET00843 | ||
| 0.089 | 0.057 | 0.166 | Ornithine decarboxylase inhibitor | 0.116 0.029 DBMET00375 0.116 0.029 DBMET00962 0.166 0.008 DBMET00843 | DBMET00843 | |
| 0.101 | 0.068 | 0.107 | Toll-Like receptor 4 antagonist | 0.107 0.059 DBMET00843 | DBMET00843 | |
| 0.052 | 0.023 | 0.052 | Benzodiazepine antagonist | |||
| 0.096 | 0.068 | 0.123 | Anabolic | 0.105 0.056 DBMET00375 0.105 0.056 DBMET00962 0.123 0.036 DBMET00843 | DBMET00843 | |
| 0.06 | 0.033 | 0.061 | Acyl-CoA dehydrogenase inhibitor | 0.061 0.033 DBMET00843 | DBMET00843 | |
| 0.079 | 0.052 | 0.079 | Na+ K+ transporting ATPase inhibitor | |||
| 0.143 | 0.117 | 0.267 | Hepatoprotectant | 0.137 0.125 DBMET00375 0.137 0.125 DBMET00962 0.267 0.039 DBMET00843 | DBMET00843 | |
| 0.035 | 0.013 | 0.036 | Elastase 3B inhibitor | 0.034 0.015 DBMET00375 0.034 0.015 DBMET00962 0.036 0.012 DBMET00843 | DBMET00843 | |
| 0.035 | 0.013 | 0.036 | Elastase 3A inhibitor | 0.034 0.015 DBMET00375 0.034 0.015 DBMET00962 0.036 0.012 DBMET00843 | DBMET00843 | |
| 0.035 | 0.013 | 0.036 | Elastase 2B inhibitor | 0.034 0.015 DBMET00375 0.034 0.015 DBMET00962 0.036 0.012 DBMET00843 | DBMET00843 | |
| 0.049 | 0.029 | 0.05 | Microtubule stabilization | 0.046 0.034 DBMET00375 0.046 0.034 DBMET00962 0.05 0.029 DBMET00843 | DBMET00843 | |
| 0.068 | 0.049 | 0.082 | Exportin-1 inhibitor | 0.082 0.022 DBMET00843 | DBMET00843 | |
| 0.116 | 0.097 | 0.15 | Protein kinase stimulant | 0.117 0.096 DBMET00375 0.117 0.096 DBMET00962 0.15 0.068 DBMET00843 | DBMET00843 | |
| 0.087 | 0.069 | 0.092 | Glutamate release inhibitor | 0.088 0.068 DBMET00375 0.088 0.068 DBMET00962 0.092 0.057 DBMET00843 | DBMET00843 | |
| 0.026 | 0.012 | 0.026 | Elastase 2A inhibitor | 0.023 0.014 DBMET00375 0.023 0.014 DBMET00962 0.022 0.016 DBMET00843 | ||
| 0.026 | 0.012 | 0.026 | Elastase 2 inhibitor | 0.023 0.014 DBMET00375 0.023 0.014 DBMET00962 0.022 0.016 DBMET00843 | ||
| 0.093 | 0.08 | 0.13 | Adenylate kinase inhibitor | 0.13 0.036 DBMET00843 | DBMET00843 | |
| 0.107 | 0.094 | 0.169 | Toll-Like receptor 2 antagonist | 0.105 0.096 DBMET00375 0.105 0.096 DBMET00962 0.169 0.04 DBMET00843 | DBMET00843 | |
| 0.088 | 0.074 | 0.169 | Aminopeptidase B inhibitor | 0.088 0.074 DBMET00375 0.088 0.074 DBMET00962 0.169 0.03 DBMET00843 | DBMET00843 | |
| 0.06 | 0.047 | 0.078 | Caspase 9 inhibitor | 0.078 0.025 DBMET00375 0.078 0.025 DBMET00962 | DBMET00962 | |
| 0.068 | 0.056 | 0.124 | Aminopeptidase I inhibitor | 0.071 0.052 DBMET00375 0.071 0.052 DBMET00962 0.124 0.018 DBMET00843 | DBMET00843 | |
| 0.056 | 0.044 | 0.059 | Lipocortins synthesis agonist | 0.054 0.051 DBMET00375 0.054 0.051 DBMET00962 0.059 0.037 DBMET00843 | DBMET00843 | |
| 0.2 | 0.188 | 0.226 | Sodium/bile acid cotransporter inhibitor | 0.226 0.155 DBMET00375 0.226 0.155 DBMET00962 | DBMET00962 | |
| 0.08 | 0.069 | 0.135 | Transcription factor NF kappa B stimulant | 0.135 0.02 DBMET00375 0.135 0.02 DBMET00962 0.094 0.046 DBMET00843 | DBMET00962 | |
| 0.082 | 0.071 | 0.082 | Falcipain inhibitor | |||
| 0.026 | 0.016 | 0.029 | Lysophosphatidic acid receptor 1 agonist | 0.029 0.012 DBMET00375 0.029 0.012 DBMET00962 0.029 0.012 DBMET00843 | DBMET00843 | |
| 0.05 | 0.042 | 0.05 | Acetyl-CoA transferase inhibitor | |||
| 0.078 | 0.072 | 0.078 | Falcipain 2 inhibitor | |||
| 0.03 | 0.024 | 0.031 | Caspase 2 inhibitor | 0.031 0.023 DBMET00843 | DBMET00843 | |
| 0.016 | 0.012 | 0.016 | Vitamin D receptor agonist | |||
| 0.013 | 0.01 | 0.016 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.01 DBMET00375 0.013 0.01 DBMET00962 0.016 0.007 DBMET00843 | DBMET00843 | |
| 0.065 | 0.065 | 0.113 | Glutamate dehydrogenase inhibitor | 0.092 0.035 DBMET00375 0.092 0.035 DBMET00962 0.113 0.025 DBMET00843 | DBMET00843 | |
| 0.133 | 0.134 | 0.193 | Angiogenesis stimulant | 0.193 0.098 DBMET00843 | DBMET00843 | |
| 0.044 | 0.046 | 0.053 | Lysophosphatidic acid 3 receptor antagonist | 0.05 0.036 DBMET00375 0.05 0.036 DBMET00962 0.053 0.032 DBMET00843 | DBMET00843 | |
| 0.047 | 0.05 | 0.055 | Vanilloid 2 antagonist | 0.049 0.046 DBMET00375 0.049 0.046 DBMET00962 0.055 0.03 DBMET00843 | DBMET00843 | |
| 0.171 | 0.178 | 0.22 | Transcription factor STAT3 inhibitor | 0.22 0.111 DBMET00375 0.22 0.111 DBMET00962 | DBMET00962 | |
| 0.059 | 0.067 | 0.173 | Catalase inhibitor | 0.065 0.059 DBMET00375 0.065 0.059 DBMET00962 0.173 0.021 DBMET00843 | DBMET00843 | |
| 0.109 | 0.118 | 0.126 | Vanilloid 1 agonist | 0.12 0.088 DBMET00375 0.12 0.088 DBMET00962 0.126 0.074 DBMET00843 | DBMET00843 | |
| 0.017 | 0.027 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.022 0.013 DBMET00843 | DBMET00843 | |
| 0.077 | 0.087 | 0.155 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.155 0.025 DBMET00843 | DBMET00843 | |
| 0.044 | 0.054 | 0.122 | Alcohol oxidase inhibitor | 0.122 0.014 DBMET00843 | DBMET00843 | |
| 0.036 | 0.047 | 0.061 | Antimetabolite | 0.061 0.025 DBMET00843 | DBMET00843 | |
| 0.039 | 0.051 | 0.057 | Ribonucleoside-diphosphate reductase inhibitor | 0.057 0.036 DBMET00843 | DBMET00843 | |
| 0.134 | 0.146 | 0.176 | Succinate dehydrogenase inhibitor | 0.176 0.073 DBMET00843 | DBMET00843 | |
| 0.082 | 0.094 | 0.124 | Expectorant | 0.106 0.062 DBMET00375 0.106 0.062 DBMET00962 0.124 0.048 DBMET00843 | DBMET00843 | |
| 0.038 | 0.053 | 0.057 | Ribonucleotide reductase inhibitor | 0.057 0.038 DBMET00843 | DBMET00843 | |
| 0.053 | 0.068 | 0.072 | Protease 3C (Human rhinovirus) inhibitor | 0.059 0.054 DBMET00375 0.059 0.054 DBMET00962 0.072 0.035 DBMET00843 | DBMET00843 | |
| 0.029 | 0.044 | 0.046 | Toll-Like receptor 2 agonist | 0.046 0.025 DBMET00843 | DBMET00843 | |
| 0.039 | 0.055 | 0.064 | Protein 50S ribosomal subunit inhibitor | 0.064 0.028 DBMET00843 | DBMET00843 | |
| 0.158 | 0.174 | 0.19 | Peptidyltransferase inhibitor | 0.189 0.113 DBMET00375 0.189 0.113 DBMET00962 0.19 0.112 DBMET00843 | DBMET00843 | |
| 0.04 | 0.058 | 0.051 | Human rhinovirus A protease inhibitor | 0.051 0.042 DBMET00375 0.051 0.042 DBMET00962 | DBMET00962 | |
| 0.065 | 0.083 | 0.069 | Vanilloid 4 agonist | 0.069 0.067 DBMET00375 0.069 0.067 DBMET00962 | DBMET00962 | |
| 0.057 | 0.075 | 0.131 | Glutamate decarboxylase inhibitor | 0.131 0.017 DBMET00843 | DBMET00843 | |
| 0.091 | 0.109 | 0.105 | Glutamate receptor antagonist | 0.105 0.09 DBMET00843 | DBMET00843 | |
| 0.083 | 0.102 | 0.121 | Adenylate cyclase inhibitor | 0.121 0.067 DBMET00843 | DBMET00843 | |
| 0.056 | 0.076 | 0.082 | Cathepsin G inhibitor | 0.082 0.042 DBMET00843 | DBMET00843 | |
| 0.175 | 0.195 | 0.251 | Transcription factor NF kappa B inhibitor | 0.242 0.133 DBMET00375 0.242 0.133 DBMET00962 0.251 0.127 DBMET00843 | DBMET00843 | |
| 0.034 | 0.054 | 0.054 | Kainate receptor agonist | 0.054 0.01 DBMET00843 | DBMET00843 | |
| 0.073 | 0.093 | 0.099 | Triose-phosphate isomerase inhibitor | 0.099 0.049 DBMET00843 | DBMET00843 | |
| 0.01 | 0.03 | 0.016 | Carbonic anhydrase X inhibitor | 0.016 0.012 DBMET00843 | DBMET00843 | |
| 0.01 | 0.03 | 0.016 | Carbonic anhydrase VIII inhibitor | 0.016 0.012 DBMET00843 | DBMET00843 | |
| 0.047 | 0.072 | 0.069 | Sphingosine kinase inhibitor | 0.069 0.026 DBMET00843 | DBMET00843 | |
| 0.043 | 0.069 | 0.095 | Carbamoyl phosphate synthetase inhibitor | 0.095 0.022 DBMET00843 | DBMET00843 | |
| 0.038 | 0.065 | 0.085 | Baculoviral IAP repeat-containing protein inhibitor | 0.085 0.004 DBMET00375 0.085 0.004 DBMET00962 | DBMET00962 | |
| 0.076 | 0.105 | 0.133 | Ferrochelatase inhibitor | 0.133 0.046 DBMET00843 | DBMET00843 | |
| 0.156 | 0.184 | 0.18 | RNA-directed DNA polymerase inhibitor | 0.18 0.132 DBMET00843 | DBMET00843 | |
| 0.082 | 0.11 | 0.118 | Mucolytic | 0.118 0.057 DBMET00843 | DBMET00843 | |
| 0.032 | 0.064 | 0.086 | Ornithine carbamoyltransferase inhibitor | 0.086 0.02 DBMET00843 | DBMET00843 | |
| 0.03 | 0.063 | 0.044 | Sphingosine kinase 1 inhibitor | 0.044 0.024 DBMET00843 | DBMET00843 | |
| 0.044 | 0.078 | 0.088 | Phosphofructokinase-1 inhibitor | 0.088 0.037 DBMET00843 | DBMET00843 | |
| 0.146 | 0.181 | 0.187 | DNA damaging | 0.187 0.127 DBMET00843 | DBMET00843 | |
| 0.012 | 0.048 | 0.022 | Aminopeptidase P inhibitor | 0.022 0.017 DBMET00843 | DBMET00843 | |
| 0.026 | 0.063 | 0.039 | Membrane dipeptidase inhibitor | 0.036 0.033 DBMET00375 0.036 0.033 DBMET00962 0.039 0.029 DBMET00843 | DBMET00843 | |
| 0.079 | 0.12 | 0.112 | Proteasome inhibitor | 0.112 0.073 DBMET00375 0.112 0.073 DBMET00962 0.11 0.075 DBMET00843 | DBMET00962 | |
| 0.044 | 0.085 | 0.061 | Nitric oxide donor | 0.061 0.047 DBMET00843 | DBMET00843 | |
| 0.018 | 0.061 | 0.037 | Fumarate hydratase inhibitor | 0.037 0.021 DBMET00843 | DBMET00843 | |
| 0.014 | 0.057 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.026 0.01 DBMET00843 | DBMET00843 | |
| 0.034 | 0.079 | 0.098 | Argininosuccinate synthase inhibitor | 0.098 0.02 DBMET00843 | DBMET00843 | |
| 0.013 | 0.061 | 0.036 | Arginase inhibitor | 0.036 0.025 DBMET00843 | DBMET00843 | |
| 0.054 | 0.103 | 0.09 | Glycine receptor agonist | 0.09 0.028 DBMET00843 | DBMET00843 | |
| 0.043 | 0.096 | 0.067 | Beta adrenoreceptor antagonist | 0.067 0.043 DBMET00375 0.067 0.043 DBMET00962 | DBMET00962 | |
| 0.157 | 0.211 | 0.188 | Neuropeptide Y2 antagonist | 0.188 0.143 DBMET00843 | DBMET00843 | |
| 0.07 | 0.126 | 0.089 | Electrolyte absorption antagonist | 0.089 0.077 DBMET00843 | DBMET00843 | |
| 0.122 | 0.178 | 0.16 | Phospholipase C inhibitor | 0.16 0.088 DBMET00843 | DBMET00843 | |
| 0.033 | 0.092 | 0.051 | Aconitate hydratase inhibitor | 0.051 0.037 DBMET00843 | DBMET00843 | |
| 0.066 | 0.129 | 0.087 | Granulocyte macrophage colony stimulating factor agonist | 0.087 0.058 DBMET00843 | DBMET00843 | |
| 0.079 | 0.145 | 0.104 | Aldehyde dehydrogenase inhibitor | 0.104 0.091 DBMET00843 | DBMET00843 | |
| 0.133 | 0.199 | 0.162 | Cardiotonic | 0.162 0.161 DBMET00843 | DBMET00843 | |
| 0.013 | 0.083 | 0.035 | Baculoviral IAP repeat-containing protein 3 inhibitor | 0.035 0.004 DBMET00375 0.035 0.004 DBMET00962 | DBMET00962 | |
| 0.034 | 0.106 | 0.061 | Carbonic anhydrase stimulant | 0.061 0.04 DBMET00843 | DBMET00843 | |
| 0.173 | 0.247 | 0.208 | GABA C receptor rho-3 antagonist | 0.208 0.198 DBMET00843 | DBMET00843 | |
| 0.147 | 0.223 | 0.204 | Nitric-oxide synthase stimulant | 0.168 0.159 DBMET00375 0.168 0.159 DBMET00962 0.204 0.082 DBMET00843 | DBMET00843 | |
| 0.069 | 0.146 | 0.102 | GABA C receptor antagonist | 0.102 0.075 DBMET00843 | DBMET00843 | |
| 0.048 | 0.127 | 0.083 | Glutamate (mGluR6) antagonist | 0.083 0.021 DBMET00843 | DBMET00843 | |
| 0.104 | 0.183 | 0.131 | Interferon gamma antagonist | 0.131 0.109 DBMET00843 | DBMET00843 | |
| 0.167 | 0.254 | 0.286 | Interleukin 2 agonist | 0.286 0.084 DBMET00843 | DBMET00843 | |
| 0.045 | 0.132 | 0.08 | Somatostatin 1 agonist | 0.08 0.051 DBMET00843 | DBMET00843 | |
| 0.014 | 0.103 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.017 DBMET00843 | DBMET00843 | |
| 0.076 | 0.167 | 0.1 | Factor V inhibitor | 0.1 0.068 DBMET00843 | DBMET00843 | |
| 0.149 | 0.242 | 0.19 | Transcription factor STAT inhibitor | 0.19 0.153 DBMET00375 0.19 0.153 DBMET00962 | DBMET00962 | |
| 0.023 | 0.119 | 0.04 | Glutamate (mGluR8) agonist | 0.04 0.022 DBMET00843 | DBMET00843 | |
| 0.033 | 0.132 | 0.084 | Phenylalanine 4-hydroxylase inhibitor | 0.084 0.034 DBMET00843 | DBMET00843 | |
| 0.005 | 0.11 | 0.016 | Baculoviral IAP repeat-containing protein 2 inhibitor | 0.016 0.003 DBMET00375 0.016 0.003 DBMET00962 | DBMET00962 | |
| 0.018 | 0.129 | 0.03 | Glutamate (mGluR3) agonist | 0.03 0.029 DBMET00843 | DBMET00843 | |
| 0.058 | 0.17 | 0.087 | GABA C receptor rho-1 antagonist | 0.087 0.083 DBMET00843 | DBMET00843 | |
| 0.093 | 0.21 | 0.128 | Melanin inhibitor | 0.128 0.119 DBMET00843 | DBMET00843 | |
| 0.079 | 0.203 | 0.154 | Phospholipase A2 inhibitor | 0.154 0.071 DBMET00843 | DBMET00843 | |
| 0.109 | 0.246 | 0.166 | Neurotensin receptor agonist | 0.166 0.068 DBMET00375 0.166 0.068 DBMET00962 0.15 0.1 DBMET00843 | DBMET00962 | |
| 0.065 | 0.226 | 0.188 | Peroxidase inhibitor | 0.188 0.063 DBMET00843 | DBMET00843 | |
| 0.044 | 0.215 | 0.096 | GABA C receptor agonist | 0.096 0.071 DBMET00843 | DBMET00843 | |
| 0.019 | 0.192 | 0.035 | Glutamate (mGluR8) antagonist | 0.035 0.026 DBMET00843 | DBMET00843 | |
| 0.103 | 0.29 | 0.227 | Superoxide dismutase inhibitor | 0.227 0.091 DBMET00843 | DBMET00843 | |
| 0.053 | 0.257 | 0.099 | DOPA decarboxylase inhibitor | 0.099 0.078 DBMET00843 | DBMET00843 | |
| 0.034 | 0.276 | 0.095 | Nitric-oxide synthase inhibitor | 0.095 0.068 DBMET00375 0.095 0.068 DBMET00962 | DBMET00962 | |
| 0.12 | 0.511 | 0.266 | Calcium channel L-type activator | 0.266 0.188 DBMET00375 0.266 0.188 DBMET00962 | DBMET00962 | |
| 0.084 | 0.488 | 0.233 | Caspase 3 stimulant | 0.233 0.128 DBMET00375 0.233 0.128 DBMET00962 | DBMET00962 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |